Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
5.82
+0.01 (0.17%)
Apr 8, 2026, 3:46 PM HKT
Charmacy Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 753.6 | 563.15 | 634.2 | 492.67 | 630.17 | Upgrade
|
| Short-Term Investments | - | 10.7 | 10.56 | 11.13 | 11.59 | Upgrade
|
| Cash & Short-Term Investments | 753.6 | 573.86 | 644.76 | 503.81 | 641.76 | Upgrade
|
| Cash Growth | 31.32% | -11.00% | 27.98% | -21.50% | 6.60% | Upgrade
|
| Accounts Receivable | 1,261 | 1,226 | 965.35 | 865.26 | 731.26 | Upgrade
|
| Other Receivables | 13.08 | 43.12 | 41.49 | 116.91 | 42.8 | Upgrade
|
| Receivables | 1,274 | 1,270 | 1,007 | 982.17 | 774.06 | Upgrade
|
| Inventory | 796.25 | 655.91 | 775.84 | 586.85 | 509.16 | Upgrade
|
| Prepaid Expenses | - | 1.84 | - | - | - | Upgrade
|
| Other Current Assets | 736.94 | 528.84 | 384.56 | 389.53 | 313.25 | Upgrade
|
| Total Current Assets | 3,561 | 3,030 | 2,812 | 2,462 | 2,238 | Upgrade
|
| Property, Plant & Equipment | 294.57 | 317.6 | 328.55 | 294.08 | 348.44 | Upgrade
|
| Goodwill | 6 | 6 | 6.02 | 6.02 | 6.02 | Upgrade
|
| Other Intangible Assets | 68.33 | 72.49 | 76.72 | 80.86 | 143.03 | Upgrade
|
| Long-Term Deferred Tax Assets | 11.48 | 7.64 | 7.38 | 6.8 | 8.16 | Upgrade
|
| Long-Term Deferred Charges | 18.69 | 22.91 | 16.98 | 16.34 | 19.21 | Upgrade
|
| Total Assets | 3,960 | 3,457 | 3,248 | 2,866 | 2,763 | Upgrade
|
| Accounts Payable | 1,405 | 826.51 | 936.49 | 876.78 | 809.77 | Upgrade
|
| Accrued Expenses | 11.68 | 61.29 | 58.35 | 86.48 | 47.84 | Upgrade
|
| Short-Term Debt | 1,119 | 1,350 | 1,338 | 1,166 | 1,193 | Upgrade
|
| Current Portion of Long-Term Debt | 13.22 | 1.22 | - | - | 31.78 | Upgrade
|
| Current Portion of Leases | - | 8.78 | 6.59 | 4.15 | 2.97 | Upgrade
|
| Current Income Taxes Payable | 64.76 | 11.72 | 12.85 | 27.05 | 6.41 | Upgrade
|
| Current Unearned Revenue | 5.02 | 2.1 | 19.49 | 13.53 | 46.66 | Upgrade
|
| Other Current Liabilities | 662.31 | 526.5 | 247.55 | 81.98 | 20.44 | Upgrade
|
| Total Current Liabilities | 3,281 | 2,789 | 2,619 | 2,256 | 2,159 | Upgrade
|
| Long-Term Debt | 38.1 | 13.8 | - | - | 86.87 | Upgrade
|
| Long-Term Leases | 24.21 | 35.17 | 30.39 | 15.75 | 12.49 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | 0.3 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.19 | 0.38 | 0.6 | 0.06 | 0.4 | Upgrade
|
| Total Liabilities | 3,344 | 2,838 | 2,650 | 2,271 | 2,259 | Upgrade
|
| Common Stock | 108 | 108 | 108 | 108 | 108 | Upgrade
|
| Additional Paid-In Capital | - | 278 | 278 | 278 | 278 | Upgrade
|
| Retained Earnings | 229.37 | 231.7 | 210.82 | 208.07 | 117.11 | Upgrade
|
| Comprehensive Income & Other | 278.99 | 0.99 | 0.99 | 0.99 | 0.99 | Upgrade
|
| Total Common Equity | 616.36 | 618.69 | 597.81 | 595.06 | 504.1 | Upgrade
|
| Shareholders' Equity | 616.36 | 618.69 | 597.81 | 595.06 | 504.1 | Upgrade
|
| Total Liabilities & Equity | 3,960 | 3,457 | 3,248 | 2,866 | 2,763 | Upgrade
|
| Total Debt | 1,195 | 1,409 | 1,375 | 1,186 | 1,327 | Upgrade
|
| Net Cash (Debt) | -441.13 | -835.6 | -729.76 | -681.72 | -685.4 | Upgrade
|
| Net Cash Per Share | -4.08 | -7.74 | -6.76 | -6.31 | -6.35 | Upgrade
|
| Filing Date Shares Outstanding | 108 | 108 | 108 | 108 | 108 | Upgrade
|
| Total Common Shares Outstanding | 108 | 108 | 108 | 108 | 108 | Upgrade
|
| Working Capital | 279.79 | 241.39 | 193.14 | 206.77 | 79.3 | Upgrade
|
| Book Value Per Share | 5.71 | 5.73 | 5.54 | 5.51 | 4.67 | Upgrade
|
| Tangible Book Value | 542.04 | 540.2 | 515.06 | 508.18 | 355.04 | Upgrade
|
| Tangible Book Value Per Share | 5.02 | 5.00 | 4.77 | 4.71 | 3.29 | Upgrade
|
| Buildings | - | 298.21 | 298.21 | 269.2 | 329.71 | Upgrade
|
| Machinery | - | 80.86 | 81.06 | 76.69 | 101.72 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.